Trait centric view

1. Trait name:	Average daily gain
   Ontology terms:	VT:0001731, CMO:0000419

   111 genes are associated with this trait, with QTL/association found

   • ABCC10: ATP-binding cassette, sub-family C (CFTR/MRP), member 10
     evidenced by: QTL:19392;
   • ABCF1: ATP-binding cassette, sub-family F (GCN20), member 1
     evidenced by: QTL:19389;
   • ABL1: ABL proto-oncogene 1, non-receptor tyrosine kinase
     evidenced by: QTL:297630;
   • ACACA: Acetyl-CoA carboxylase alpha
     evidenced by: QTL:193138; QTL:24098; QTL:24102;
   • ACSS3: Acyl-CoA synthetase short-chain family member 3
     evidenced by: QTL:28889;
   • ADAMTS2: ADAM metallopeptidase with thrombospondin type 1 motif 2
     evidenced by: QTL:315079;
   • AGL: Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
     evidenced by: QTL:12065; QTL:12066;
   • ALPK2: Alpha kinase 2
     evidenced by: QTL:216141; QTL:216189; QTL:297628;
   • ATG9A: Autophagy related 9A
     evidenced by: QTL:19432;
   • ATXN10: Ataxin 10
     evidenced by: QTL:28822;
   • BRPF3: Bromodomain and PHD finger containing 3
     evidenced by: QTL:312428;
   • C7H6ORF106: Chromosome 6 open reading frame 106 ortholog
     evidenced by: QTL:312340;
   • CABLES1: Cdk5 and Abl enzyme substrate 1
     evidenced by: QTL:28840;
   • CATSPERB: Cation channel sperm associated auxiliary subunit beta
     evidenced by: QTL:297640;
   • CBLN4: Cerebellin 4 precursor
     evidenced by: QTL:28081;
   • CCBE1: Collagen and calcium binding EGF domains 1
     evidenced by: QTL:297626;
   • CCKAR: Cholecystokinin A receptor
     evidenced by: QTL:10590; QTL:10596; QTL:10597; QTL:10598; QTL:10599;
   • CCND2: Cyclin D2
     evidenced by: QTL:315081;
   • CDH20: Cadherin 20
     evidenced by: QTL:216137; QTL:216193; QTL:315087;
   • CDHR2: Cadherin related family member 2
     evidenced by: QTL:315080;
   • CEL: Carboxyl ester lipase
     evidenced by: QTL:312375;
   • CEP68: Centrosomal protein 68
     evidenced by: QTL:216150;
   • CORO2B: Coronin, actin binding protein, 2B
     evidenced by: QTL:28802;
   • CPE: Carboxypeptidase E
     evidenced by: QTL:297641;
   • CPLANE1: Ciliogenesis and planar polarity effector 1
     evidenced by: QTL:194043;
   • CPLX4: Complexin 4
     evidenced by: QTL:297629;
   • CPT1A: Carnitine palmitoyltransferase 1A
     evidenced by: QTL:170639;
   • CREB3L2: CAMP responsive element binding protein 3 like 2
     evidenced by: QTL:194047;
   • CRH: Corticotropin releasing hormone
     evidenced by: QTL:16959;
   • CSTF1: Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa
     evidenced by: QTL:9784; QTL:9785;
   • CTSD: Cathepsin D
     evidenced by: QTL:11855; QTL:11902; QTL:11907;
   • CTSK: Cathepsin K
     evidenced by: QTL:10409;
   • CTSS: Cathepsin S
     evidenced by: QTL:12118;
   • CTSZ: Cathepsin Z
     evidenced by: QTL:11864; QTL:9779; QTL:9780;
   • DLK1: Delta-like 1 homolog (Drosophila)
     evidenced by: QTL:8696;
   • EFCAB6: EF-hand calcium binding domain 6
     evidenced by: QTL:28825;
   • EPRS: Glutamyl-prolyl-tRNA synthetase
     evidenced by: QTL:19400;
   • FASN: Fatty acid synthase
     evidenced by: QTL:193130;
   • FKBP10: FK506 binding protein 10, 65 kDa
     evidenced by: QTL:19421; QTL:19423;
   • FRMD4B: FERM domain containing 4B
     evidenced by: QTL:315086;
   • FTO: Fat mass and obesity associated
     evidenced by: QTL:32781;
   • GBP1: Guanylate binding protein 1, interferon-inducible
     evidenced by: QTL:101299; QTL:101300; QTL:101301; QTL:101302; QTL:101303; QTL:238180; QTL:238182;
   • GBP5: Guanylate binding protein 5
     evidenced by: QTL:238178;
   • GGH: Gamma-glutamyl hydrolase
     evidenced by: QTL:312446;
   • GHRL: Ghrelin/obestatin prepropeptide
     evidenced by: QTL:176518; QTL:176520;
   • GPAT3: Glycerol-3-phosphate acyltransferase 3
     evidenced by: QTL:135784; QTL:135786; QTL:135788; QTL:135789;
   • GSR: Glutathione-disulfide reductase
     evidenced by: QTL:297645;
   • HDAC4: Histone deacetylase 4
     evidenced by: QTL:312373; QTL:312374;
   • HS2ST1: Heparan sulfate 2-O-sulfotransferase 1
     evidenced by: QTL:28819;
   • HTR3B: 5-hydroxytryptamine receptor 3B
     evidenced by: QTL:259469;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:11892; QTL:11897;
   • IGSF3: Immunoglobulin superfamily, member 3
     evidenced by: QTL:28811;
   • INPPL1: Inositol polyphosphate phosphatase-like 1
     evidenced by: QTL:194101;
   • IZUMO2: IZUMO family member 2
     evidenced by: QTL:315091;
   • KDM2A: Lysine (K)-specific demethylase 2A
     evidenced by: QTL:17580; QTL:17581;
   • LAMA3: Laminin, alpha 3
     evidenced by: QTL:28841;
   • LDHA: Lactate dehydrogenase A
     evidenced by: QTL:160585; QTL:9821;
   • LEMD2: LEM domain nuclear envelope protein 2
     evidenced by: QTL:312337; QTL:312338; QTL:312339;
   • LEP: Leptin
     evidenced by: QTL:18523;
   • LOC100737013: Liver carboxylesterase-like
     evidenced by: QTL:28893;
   • LRRK2: Leucine-rich repeat kinase 2
     evidenced by: QTL:3091;
   • LURAP1: Leucine rich adaptor protein 1
     evidenced by: QTL:194080;
   • MAOA: Monoamine oxidase A
     evidenced by: QTL:24218;
   • MAP3K4: Mitogen-activated protein kinase kinase kinase 4
     evidenced by: QTL:312371; QTL:312372;
   • MC4R: Melanocortin 4 receptor
     evidenced by: QTL:10621; QTL:10622; QTL:10623; QTL:10624; QTL:10625; QTL:10626; QTL:21338; QTL:21342; QTL:9798; QTL:9799;
   • MCF2L: MCF.2 cell line derived transforming sequence like
     evidenced by: QTL:216197;
   • MPIG6B: Megakaryocyte and platelet inhibitory receptor G6b
     evidenced by: QTL:315093;
   • MSTN: Myostatin
     evidenced by: QTL:24024;
   • MUC4: Mucin 4, cell surface associated
     evidenced by: QTL:24021; QTL:24023;
   • MVB12B: Multivesicular body subunit 12B
     evidenced by: QTL:262473;
   • NMNAT2: Nicotinamide nucleotide adenylyltransferase 2
     evidenced by: QTL:194102;
   • NR6A1: Nuclear receptor subfamily 6 group A member 1
     evidenced by: QTL:286054;
   • NSMAF: Neutral sphingomyelinase activation associated factor
     evidenced by: QTL:312370;
   • NTRK2: Neurotrophic receptor tyrosine kinase 2
     evidenced by: QTL:315083;
   • NUCB2: Nucleobindin 2
     evidenced by: QTL:28213;
   • NUDT3: Nudix (nucleoside diphosphate linked moiety X)-type motif 3
     evidenced by: QTL:312344; QTL:312345; QTL:312346;
   • OSBPL1A: Oxysterol binding protein-like 1A
     evidenced by: QTL:28842;
   • PGD: Phosphogluconate dehydrogenase
     evidenced by: QTL:7666;
   • PHLPP1: PH domain and leucine rich repeat protein phosphatase 1
     evidenced by: QTL:216143;
   • PIK3C3: Phosphatidylinositol 3-kinase, catalytic subunit type 3
     evidenced by: QTL:17631;
   • PLCB4: Phospholipase C, beta 4
     evidenced by: QTL:28912;
   • PRIM2: Primase, DNA, polypeptide 2 (58kDa)
     evidenced by: QTL:216151;
   • PRKAG3: Protein kinase, AMP-activated, gamma 3 non-catalytic subunit
     evidenced by: QTL:285985; QTL:285993;
   • PRKG1: Protein kinase cGMP-dependent 1
     evidenced by: QTL:297644;
   • PRPF18: Pre-mRNA processing factor 18
     evidenced by: QTL:297642;
   • PRR2: Poliovirus receptor related 2
     evidenced by: QTL:28834;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:194050;
   • PTGIS: Prostaglandin I2 (prostacyclin) synthase
     evidenced by: QTL:19441;
   • RELCH: RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing
     evidenced by: QTL:216146;
   • RNF103: Ring finger protein 103
     evidenced by: QTL:19374;
   • RNF115: Ring finger protein 115
     evidenced by: QTL:312444;
   • RNF152: Ring finger protein 152
     evidenced by: QTL:216147; QTL:297636;
   • RTFDC1: Protein RTF2 homolog
     evidenced by: QTL:9788;
   • RYR1: Ryanodine receptor 1 (skeletal)
     evidenced by: QTL:7669;
   • SCD5: Stearoyl-CoA desaturase 5
     evidenced by: QTL:19394;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:24028; QTL:24030;
   • SCUBE1: Signal peptide, CUB domain, EGF-like 1
     evidenced by: QTL:28826;
   • SKAP1: Src kinase associated phosphoprotein 1
     evidenced by: QTL:315085;
   • SLA-1: MHC class I antigen 1
     evidenced by: QTL:312334;
   • SOCS2: Suppressor of cytokine signaling 2
     evidenced by: QTL:35213; QTL:9876;
   • SOGA1: Suppressor of glucose, autophagy associated 1
     evidenced by: QTL:130550;
   • SPAG17: Sperm associated antigen 17
     evidenced by: QTL:28810;
   • ST18: ST18 C2H2C-type zinc finger transcription factor
     evidenced by: QTL:312441; QTL:312442;
   • SYNPO2: Synaptopodin 2
     evidenced by: QTL:28862;
   • TEF1: Transcriptional enhancer factor 1
     evidenced by: QTL:8636; QTL:8637;
   • TG: Thyroglobulin
     evidenced by: QTL:194056;
   • TGFBR1: Transforming growth factor, beta receptor 1
     evidenced by: QTL:18540; QTL:18541; QTL:18543;
   • TNS1: Tensin 1
     evidenced by: QTL:194041;
   • TRIM55: Tripartite motif containing 55
     evidenced by: QTL:17596;
   • UBL5: Ubiquitin-like 5
     evidenced by: QTL:28218;
   • VAV3: Vav 3 guanine nucleotide exchange factor
     evidenced by: QTL:28814;
   992 correlations are found involving Average daily gain